Last updated on December 2018

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atrial Fibrillation | Stroke
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other:
    Age =>18 years at enrollment
    Male or female patient (or legally acceptable representative) willing and able to
    provide written informed consent
    Patient newly diagnosed (< 3 months prior to baseline visit) with non-valvular AF and
    at risk for stroke.
    Other inclusion criteria apply.

You may not be eligible for this study if the following are true:

  • Presence of any mechanical heart valve, or valve disease that is expected to require
    valve replacement intervention;
    Patients who have received more than 60 days of vitamin K antagonist (VKA) treatment
    in their lifetime;
    AF with a generally reversible cause;
    Patients with a medical condition other than atrial fibrillation for which chronic use
    of an oral anticoagulant (for example, a VKA) is indicated Other exclusion criteria

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.